MetLife Investment Management’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-7,156
Closed -$978K 2665
2018
Q2
$978K Hold
7,156
0.01% 1026
2018
Q1
$564K Hold
7,156
0.01% 1302
2017
Q4
$488K Buy
+7,156
New +$371K 0.01% 1406

MetLife Investment Management's FMI Position: Q3 2018 in Review

MetLife Investment Management sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 7,156 shares — an estimated $978K sold.

MetLife Investment Management first reported a position in FMI in Q4 2017 and held it in 3 quarters. The position peaked at $978K in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • MetLife Investment Management reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • MetLife Investment Management sold 7,156 Foundation Medicine, Inc. shares in Q3 2018, an estimated $978K.
  • MetLife Investment Management first reported a position in Foundation Medicine, Inc. in Q4 2017 and held it in 3 quarters.
  • MetLife Investment Management's Foundation Medicine, Inc. position peaked at $978K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on MetLife Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.